Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies
Cosimo Andrea Stamerra1,2, Paolo Di Giosia1,2, Paolo Giorgini1
1University of L'Aquila, Department of Life, Health and Environmental Sciences, Building Delta 6, San Salvatore Hospital, Via Vetoio, Coppito 67100 L'Aquila, Italy.
Oxidative Medicine and Cellular Longevity
|August 12, 2022
Summary
Mitochondrial dysfunction impairs cellular energy production, increasing reactive oxygen species. Therapies targeting this dysfunction for cardiovascular diseases show promise, but clinical evidence remains limited due to a lack of large randomized studies.
Area of Science:
- Cellular biology
- Biochemistry
- Cardiovascular research
Background:
- Mitochondria generate cellular energy (ATP) via oxidative phosphorylation.
- Mitochondrial dysfunction disrupts ATP production and increases reactive oxygen species (ROS).
- Dysfunction stems from genetic mutations or secondary to cardiovascular disease, aging, and environmental factors.
Purpose of the Study:
- Investigate the therapeutic potential of targeting mitochondrial dysfunction in cardiovascular diseases.
- Address the growing interest in mitochondrial-based therapies for heart conditions.
Main Methods:
- Review of existing preclinical and clinical data on mitochondrial dysfunction therapies.
- Analysis of studies focusing on ATP production and ROS in cardiovascular contexts.
Main Results:
- Numerous preclinical studies support interventions for mitochondrial dysfunction.
- A significant lack of large-scale, randomized clinical trials hinders definitive conclusions.
Conclusions:
- Therapeutic strategies for mitochondrial dysfunction in cardiovascular disease are under active investigation.
- Further large-scale clinical trials are essential to validate preclinical findings and establish treatment efficacy.
More Related Videos
Related Concept Videos
01:45Mitochondrial Membranes
12.0K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
12.0K
01:46Electron Transport Chain: Complex I and II
14.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
01:26Coronary Artery Disease II: Pathophysiology
28
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:29Pathophysiology of Cardiac Performance
784
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
784
01:29Heart Failure II: Pathophysiology
31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31